The sheer speed of developing and gaining regulatory approval for effective vaccines against Covid-19 has been unprecedented. Transporting them rapidly and safely from manufacturing sites to vaccination centres and doctors’ surgeries across the world is possibly the biggest challenge the logistics industry has ever faced.
More than a dozen different vaccines have now been authorised for use in various countries with several more in Phase 3 trials, anticipating roll outs in 2021. Pfizer has stated its intention to produce up to 1.3 billion doses of its Covid-19 vaccine in 2021, whilst Moderna projects between 600 million and one billion doses in the same period.
